Press Releases Biofrontera Inc.

Equities

BFRI

US09077D2099

Delayed Nasdaq Other stock markets 13:54:19 2024-04-29 EDT			5-day change	1st Jan Change
1.7 ^USD	+6.92%		+17.65%	-38.63%

03-18	Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024
03-15	Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	02-21	AQ
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	02-21	AQ
Biofrontera : Notes to the Consolidated Financial Statements - Form 8-K	23-10-03	PU
SciBase strengthens US team with experienced Dermatology executive	23-09-04	AQ
BIOFRONTERA INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-06-02	AQ
Biofrontera : Begins Development of a Portable Photodynamic Therapy Lamp for Use with Ameluz®-PDT - Form 8-K	23-06-01	PU
BIOFRONTERA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-06-01	AQ
Biofrontera : Names Founder and Executive Chairman Hermann Luebbert as Chief Executive Officer - Form 8-K	23-05-30	PU
BIOFRONTERA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-30	AQ
Biofrontera : Failure to Satisfy Listing Rule - Form 8-K	23-05-26	PU
BIOFRONTERA INC. : Results of Operations and Financial Condition, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-05-12	AQ
BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits (form 8-K)	23-04-28	AQ
BIOFRONTERA INC. : Entry into a Material Definitive Agreement (form 8-K)	23-04-17	AQ
BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-13	AQ
BIOFRONTERA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-03-02	AQ
Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of Stockholders	22-12-16	AQ
BIOFRONTERA INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)	22-12-16	AQ
Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference	22-11-30	GL
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022	22-11-28	GL
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022	22-11-28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Biofrontera Inc.

Equities

BFRI

US09077D2099

Press Releases

Filters